Clinical Trial

Multisite rTMS for Mood, Cognitive Impairment and Other Symptoms of Depression

Recruiting
View on ClinicalTrials.gov →
Summary
Depressed mood is the main symptom of depression, but other symptoms like cognitive impairment, anhedonia or sleep disorders may also contribute to patients suffering and are difficult to treat. rTMS is a relatively novel treatment option, whose therapeutic potential is still investigated and optimized. The aim of this study is to assess the effect of rTMS applied over two stimulation sites on cognitive impairment, anhedonia and sleep disorders in depression.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-09; most recent amendment 2024-10-09.
Status change: Not Yet Recruiting → Recruiting 2024-10-09
Trial Details
NCT Number NCT06363981
Lead Sponsor Jakub Antczak
Collaborators: Andrzej Frycz Modrzewski Krakow University
Conditions Unipolar Depression, Bipolar Disorder
Enrollment 90 participants
Start Date 2024-05-20
Primary Completion 2026-12 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2024-10-15